Diabetes Care: There is an increased demand for pacemaker therapy in people with type 2 diabetes.

People with type 2 diabetes have an increased risk of cardiovascular disease, including arrhythmic disorders.
in contemporary patient populations, there has been less research on the prevalence of chronic arrhythmic disorders and the subsequent use of pacemakers (PM) for treatment.
, a recent study published in Diabetes Care, an authoritative journal in the field of diabetes, looked at whether people with type 2 diabetes had an increased need for PM implants compared to those who did not have age and gender matching, and 2) patient characteristics associated with increased demand for PM.
In this population matching registration study, a total of 416,247 people with type 2 diabetes from the Swedish National Diabetes Registry and 208,1235 age and gender matching controls were included in the study between 1 January 1998 and 31 December 2012.
until 31 December 2013, the average follow-up time was seven years.
researchers conducted a Cox proportional risk regression analysis to estimate the need for PM treatment and identify patient characteristics with such needs.
type 2 diabetes is associated with increased demand for PM treatment (risk ratio of 1.65 (95% CI is 1.60-1.69) ;P-lt;0.0001), in Adjustment of age, sex, level of education, marital status, country of birth and continuity after coronary heart disease (1.56 (1.51-1.60) ;P-lt;0.0001).
risk factors for PM treatment include age, HbA1c, BMI, diabetes course, and blood lipid and blood pressure medications.
result, people with type 2 diabetes are more in need of PM treatment than in a control group based on matching populations.
age, diabetes course and HbA1c appear to be risk factors for PM treatment.
.